REDCO HEALTHY (02370) has released its interim results for the 2026 fiscal year, reporting revenue of approximately RMB 194 million, a decrease of about 7.2% compared with the same period last year.
Gross profit stood at around RMB 38.9 million, down approximately 25.5% year-on-year. The loss attributable to owners of the company narrowed to roughly RMB 2.6 million, representing a reduction of 55.14% from the prior corresponding period. Loss per share was RMB 1.29 cents.
The results reflect ongoing cost-control measures and operational adjustments amid a challenging market environment, contributing to the improved bottom-line performance during the reporting period.
Comments